Posted by Michael Wonder on 17 Oct 2023
First treatment to be recommended by NICE at the same time it is approved for advanced lymphoma in the UK
17 October 2023 - More than 700 people set to benefit from new treatment option for advanced lymphoma.
NICE has recommended glofitamab as a new treatment option for adults with relapsed or refractory diffuse large B cell lymphoma after two or more systemic treatments in final guidance published today.
Today’s recommendation for its use in the NHS coincides with glofitamab receiving its licence from the MHRA.
